Table 4 Fisher's exact test between RXRs cytoplasmic expression and different clinicopathological data of the patients presenting infiltrative carcinomas.
RXR-α C | RXR-β C | RXR-γ C | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Negative | Weak | High | p-value | Negative | Weak | High | p-value | Negative | Weak | High | p-value | ||
Tumor Type | Ductal | 30 | 3 | 21 | 0.264 | 24 | 12 | 18 | 0.838 | 19 | 10 | 25 | 0.151 |
Lobular | 14 | 3 | 5 | 10 | 6 | 6 | 13 | 2 | 7 | ||||
Age | <50 | 12 | 3 | 4 | 0.185 | 10 | 4 | 5 | 0.765 | 5 | 3 | 11 | 0.254 |
>50 | 33 | 3 | 22 | 25 | 14 | 19 | 27 | 9 | 22 | ||||
Tumor size | 1 | 15 | 4 | 12 | 0.697 | 12 | 11 | 8 | 0.292 | 15 | 7 | 9 | 0.392 |
2 | 22 | 2 | 9 | 17 | 4 | 12 | 12 | 5 | 16 | ||||
3 | 3 | 0 | 2 | 1 | 2 | 2 | 2 | 0 | 3 | ||||
4 | 5 | 0 | 3 | 5 | 1 | 2 | 3 | 0 | 5 | ||||
Nodal status | - | 22 | 3 | 10 | 0.678 | 17 | 12 | 6 | 0.024 | 18 | 9 | 8 | 0.003 |
+ | 23 | 3 | 16 | 18 | 6 | 18 | 14 | 3 | 25 | ||||
ER | 0 | 10 | 0 | 7 | 0.274 | 6 | 2 | 9 | 0.060 | 2 | 3 | 12 | 0.000 |
1 | 6 | 0 | 0 | 3 | 0 | 3 | 1 | 0 | 5 | ||||
2 | 6 | 2 | 4 | 4 | 6 | 2 | 2 | 4 | 6 | ||||
3 | 23 | 4 | 15 | 22 | 10 | 10 | 27 | 5 | 10 | ||||
PR | 0 | 13 | 1 | 7 | 0.296 | 11 | 5 | 5 | 0.480 | 9 | 2 | 10 | 0.009 |
1 | 7 | 0 | 0 | 3 | 0 | 4 | 0 | 0 | 7 | ||||
2 | 8 | 1 | 4 | 5 | 5 | 3 | 4 | 5 | 4 | ||||
3 | 17 | 4 | 15 | 16 | 8 | 12 | 19 | 5 | 12 | ||||